Varian Medical Systems, Inc. (NYSE:VAR) was founded in 1948, formerly known as Varian Associates, Inc., changed its current name in April 1999, and is headquartered in Palo Alto, California, USA, with 7,000 full-time employees, is the world’s largest manufacturer of oncology radiotherapy equipment and software.
Varian Medical Systems (VAR):
Varian was originally founded in 1948 under the leadership of Russell H. Varian, Sigurd F. Varian, William Webster Hansen and Edward Ginzton, and was named Varian Associates at the time. It mainly sold accelerators, electromagnetic tubes and other electromagnetic equipment.
On April 2, 1999, Varian Associates was split into three companies : Varian Semiconductor (NASDAQ: VSEA, delisted) and Varian, Inc. (NASDAQ: VARI, delisted) And Varian Medical Systems.
Varian Medical Systems is the world’s largest manufacturer of oncology radiation equipment and software systems. It designs and manufactures cancer radiation equipment and software products. These medical devices include linear accelerators and software for the treatment of cancer and other diseases, radiotherapy and radiosurgery. , Proton therapy and brachytherapy.
The software provided by Varian Medical Systems is used to manage comprehensive cancer clinical institutions, radiotherapy centers and medical oncology institutions. Varian is a supplier of medical diagnostics, dentistry, veterinary care, science, safety, industrial inspection, tubes and digital detectors including high-energy X-ray technology for cargo screening X-ray imaging.
Varian Medical Systems (VAR) acquisition and spin-off of Wikipedia:
Varian Medical Systems has acquired a number of companies, including: Pan-Pacific Enterprises, ACCEL Instruments, Bio-Imaging Research, Inc. Sigma Micro Informatique Conseil, Argus Software, Velocity Medical Solutions. and MeVis Medical Solutions AG.
On January 30, 2017, Varian Medical Systems completed the spin-off of its Varex Imaging Corporation (manufacturing X-ray imaging products) business.
In January 2018, Varian Medical Systems announced the acquisition of Sirtex Medical for USD 1.3 billion.
Varian Medical Systems (VAR) news:
January 2019: Varian’s breakthrough smart radiotherapy platform—Halcyon™ officially launched in China
Varian’s Halcyon™ smart radiotherapy platform was officially launched in China-this is a new generation of smart radiotherapy platform with epoch-making significance. It aims to empower front-line medical workers with innovative technologies and comprehensively improve clinical efficiency, treatment quality, operational efficiency and Patient experience, promote the popularization and standardized development of advanced radiotherapy technologies in China, and benefit more Chinese cancer patients.
The development and production of the Halcyon system is centered on the needs of the Chinese market. It is the world’s first medical linear accelerator to achieve 100% image guidance. It has the advantages of high integration, high automation, and high intelligence, which further promotes radiotherapy from “traditional precision radiotherapy” To “Smart Precise Radiotherapy”. Currently in China, only 24.3% of radiotherapy units are capable of image-guided therapy. The introduction of the Halcyon system will fully upgrade China’s radiotherapy technology capabilities.
For its innovation and technological breakthroughs, Halcyon won the 2018 R&D 100 Award, which recognizes pioneers leading the advancement of science and technology, and is the most prestigious innovation award program in the field of research and development. For example, the Halcyon system brings a new generation of “Gemini” fast double-layer multi-leaf collimator (MLC), which doubles the speed of blade movement to support the frame rotation of the Halcyon system at four times the speed, and the “stacked staggered” design greatly reduces Leakage between leaves, 100% full coverage of the field area, the powerful modulation capabilities demonstrated by the new MLC have brought the simultaneous improvement of the quality and efficiency of the treatment plan.
The Halcyon system adheres to the “people-oriented” design concept, improves patient comfort, is easy to use by medical staff, has short installation and acceptance testing time, simple training, and treatment automation. The system is designed to simplify the complex, simplify the implementation of image-guided radiotherapy, and completely change the clinical workflow. It is suitable for the treatment of most cancer patients, and can implement advanced treatments for prostate cancer, breast cancer, head and neck tumors and other types of tumors.
The Halcyon system uses Varian Eclipse™/RapidPlan™ radiation therapy planning software to implement high-quality planning and treatment. In March 2018, Eclipse helped Varian users win the highest score in the general category of the first World Therapy Planning Championship hosted by ProKnow, taking the top four in the general category and occupying six places in the top ten.
As a new generation of smart radiotherapy platform, the Halcyon system can be connected to the Varian Zhiyun 4.0 radiotherapy platform, using big data, artificial intelligence, and industrial Internet of Things technologies to realize the intelligent integration of people, machines, data, and the Internet of Things, and provide users with trend forecasts. All-round intelligent connection services such as judgment, forward-looking maintenance, remote quality control, remote diagnosis, remote planning, and remote treatment process management. Under the protection of the Zhiyun 4.0 radiotherapy platform, the Halcyon system can be deployed in the medical consortium to ensure that the primary hospitals can safely, standardly and effectively carry out treatment under the real-time guidance of the specialist medical consortium, which opens the true medical consortium radiotherapy. Cloud era.
Since its launch in May 2017, the Halcyon system has quickly been approved and certified in the United States, Europe, Japan, Brazil, India, Taiwan and other countries and regions. At present, Varian has received more than 200 global orders. The world’s leading tumor centers, such as the University of Pennsylvania Medical Center, MD Anderson Cancer Center, Leuven University Hospital in Belgium, and ICON Medical Group in Australia, have all become the first users of the Halcyon system. In September 2017, the University of Pennsylvania Medical Center completed the world’s first treatment of the Halcyon system and successfully treated a patient with a head and neck tumor.
Varian Medical Systems (VAR) acquires Baike:
- Varian Medical Systems successively acquired Pan-Pacific Enterprises, ACCEL Instruments, Bio-Imaging Research, Inc., Sigma Micro Informatique Conseil, Argus Software, Velocity Medical Solutions, MeVis Medical Solutions AG.
- In January 2017, Varian Medical Systems divested its medical X-ray tube and image processing solutions business and became an independent listed company- Varex Imaging Corporation .
- On May 7, 2018, Varian announced that it had completed the acquisition of Cooperative CL Enterprises, the leading radiotherapy equipment distributor in Taiwan.